Sectors

Existing investors including Foxconn, SK Telecom and iA Financial could buy up to $80m of shares in the medical imaging system developer's initial public offering.

UCSF spinout Mission Bio has pushed its overall funding to more than $120m following a series C round led by Novo Growth.

Ziegler Link-Age contributed to a round for SoftBank-backed financial wellness service PayActiv that increased its overall funding to $133m.

Agilent Ventures has taken part in a Novo Growth-led round that brought the precision medicine technology developer's overall funding to more than $120m.

The real estate investor has secured CBRE as a limited partner for a property technology fund slated to close at $100m by the end of 2020.

Mitsubishi UFJ Lease & Finance and Fuyo General Lease are among the limited partners for the unit's third fund, following its opening of an office in Japan.

Bertelsmann vehicle BDMI was among the investors that helped push the overall equity funding for charity crowdfunding platform Omaze past the $50m mark.

The San Francisco Giants are among the investors that provided the funding for the in-game betting technology startup over multiple rounds.

Amid the covid-19 pandemic, interest in life sciences is now perhaps at its highest. This is true in corporate venture capital and three of the multimillion-dollar stories we reported in mid-August corroborate this.

Kunlun Tech returned to reinvest in a $21.6m round for the cardiovascular imaging system provider, which is also working on a device for coronavirus diagnosis.

Boehringer Ingelheim Venture Fund led an $11.2m series A round for Bodyport, developer of a cardiovascular disease detection system.